Richmond's Phlow closes $36M Series B round

The public benefit corporation seeks to manufacture high-quality, essential generic drugs at a low cost.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.